These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23592512)

  • 61. Current recommendations: Screening for Mendelian disorders.
    Rose NC; Wick M
    Semin Perinatol; 2016 Feb; 40(1):23-8. PubMed ID: 26706396
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patient preferences for prenatal testing and termination of pregnancy for congenital anomalies and genetic diseases in Ethiopia.
    Brooks D; Asta K; Sturza J; Kebede B; Bekele D; Nigatu B; Hewison J; Quinonez SC
    Prenat Diagn; 2019 Jul; 39(8):595-602. PubMed ID: 31063215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antenatal noninvasive DNA testing: clinical experience and impact.
    Ferres MA; Hui L; Bianchi DW
    Am J Perinatol; 2014 Aug; 31(7):577-82. PubMed ID: 24683075
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis.
    Chiu RW; Lo YM
    Expert Rev Mol Diagn; 2002 Jan; 2(1):32-40. PubMed ID: 11963800
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Update in non-invasive prenatal testing.
    D'ambrosio V; Squarcella A; Vena F; Di Mascio D; Corno S; Pajno C; Piccioni MG; Brunelli R; Pizzuti A; Benedetti Panici P; Giancotti A
    Minerva Ginecol; 2019 Feb; 71(1):44-53. PubMed ID: 30318870
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prenatal screening and diagnosis for pediatricians.
    Cunniff C;
    Pediatrics; 2004 Sep; 114(3):889-94. PubMed ID: 15342871
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prenatal exclusion of recessively inherited disorders: should maternal plasma analysis precede invasive techniques?
    Bianchi DW
    Clin Chem; 2002 May; 48(5):689-90. PubMed ID: 11978594
    [No Abstract]   [Full Text] [Related]  

  • 68. Cervical trophoblasts for non-invasive single-cell genotyping and prenatal diagnosis.
    Pfeifer I; Benachi A; Saker A; Bonnefont JP; Mouawia H; Broncy L; Frydman R; Brival ML; Lacour B; Dachez R; Paterlini-Bréchot P
    Placenta; 2016 Jan; 37():56-60. PubMed ID: 26680636
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing.
    Lenaerts L; Van Calsteren K; Che H; Vermeesch JR; Amant F
    Prenat Diagn; 2019 Nov; 39(12):1162-1165. PubMed ID: 31393011
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Next generation sequencing and its applications in non-invasive prenatal testing of aneuploidies].
    Babay LÉ; Horányi D; Rigó J; Nagy GR
    Orv Hetil; 2015 Jun; 156(26):1041-8. PubMed ID: 26104666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Molecular genetic testing in amniotic fluid].
    Simon-Bouy B; Mornet E
    Gynecol Obstet Fertil; 2002 Apr; 30(4):325-30. PubMed ID: 12043509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prenatal screening of single-gene disorders from maternal blood.
    Sekizawa A; Saito H
    Am J Pharmacogenomics; 2001; 1(2):111-7. PubMed ID: 12174672
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies.
    Hahn S; Jackson LG; Kolla V; Mahyuddin AP; Choolani M
    Expert Rev Mol Diagn; 2009 Sep; 9(6):613-21. PubMed ID: 19732005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessment.
    Walsh JM; Goldberg JD
    Prenat Diagn; 2013 Jun; 33(6):514-20. PubMed ID: 23686655
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Noninvasive prenatal testing: from aneuploidy to single genes.
    Guseh SH
    Hum Genet; 2020 Sep; 139(9):1141-1148. PubMed ID: 31555907
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Noninvasive prenatal testing using cell-free fetal DNA in maternal plasma.
    Dharajiya N; Zwiefelhofer T; Guan X; Angkachatchai V; Saldivar JS
    Curr Protoc Hum Genet; 2015 Jan; 84():8.15.1-8.15.20. PubMed ID: 25599670
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prenatal diagnosis for late-onset disease--always room for discussion.
    Cox SM; Yew S; Nisker J
    Fertil Steril; 2005 Jun; 83(6):1887-8; author reply 1888. PubMed ID: 15950678
    [No Abstract]   [Full Text] [Related]  

  • 78. Prenatal genetic screening.
    Grant SS
    Online J Issues Nurs; 2000; 5(3):2. PubMed ID: 11380268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cell-free fetal nucleic acid testing: a review of the technology and its applications.
    Sayres LC; Cho MK
    Obstet Gynecol Surv; 2011 Jul; 66(7):431-42. PubMed ID: 21944155
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-invasive prenatal testing for Down syndrome.
    Twiss P; Hill M; Daley R; Chitty LS
    Semin Fetal Neonatal Med; 2014 Feb; 19(1):9-14. PubMed ID: 24210903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.